![](/img/cover-not-exists.png)
Prospective validation of the PML risk biomarker l-Selectin and influence of natalizumab extended intervals
Schwab, Nicholas, Schneider-Hohendorf, Tilman, Pignolet, Béatrice, Bucciarelli, Florence, Scandella, Lise, Ciron, Jonathan, Biotti, Damien, Lebrun-Frenay, Christine, Mathey, Guillaume, Clavelou, PierrLanguage:
english
Journal:
Neurology
DOI:
10.1212/WNL.0000000000008135
Date:
August, 2019
File:
PDF, 353 KB
english, 2019